Company intelligence / Profile preview

BioSig AI Sciences

Westport, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

BioSig AI Sciences is developing an artificial intelligence platform for hospitals, leveraging electrocardiogram and intracardiac electrogram data from the FDA-cleared PURE EP™ Platform, with early-stage collaborations and infrastructure-building underway; clinical outcome data not yet available.[1][3][7]

Therapeutic areas: Cardiovascular
Modalities: DeviceArtificial intelligence platform
Industry: Digital Health Medical Devices

Partnerships

NVIDIA Inception (AI+healthcare R&D support)[1][3]Technology/data infrastructure partner (undisclosed, major global technology org)[3]Reified Labs (AI research and patents, ongoing, since 2019)[2]Technion (Israel Institute of Technology; Feasibility/research collaboration for AI in ECG signal analysis)[5]

Beyond the preview

Go deeper on BioSig AI Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSig AI Sciences.

Explore the full profile